BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34262132)

  • 1. Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders.
    Mithraprabhu S; Chen M; Savvidou I; Reale A; Spencer A
    Leukemia; 2021 Oct; 35(10):2771-2783. PubMed ID: 34262132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities.
    Heestermans R; Schots R; De Becker A; Van Riet I
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer.
    Romano C; Martorana F; Pennisi MS; Stella S; Massimino M; Tirrò E; Vitale SR; Di Gregorio S; Puma A; Tomarchio C; Manzella L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid Biopsy: A New Tool in Oncology.
    Costa JL; Schmitt FC
    Acta Cytol; 2019; 63(6):448. PubMed ID: 31266005
    [No Abstract]   [Full Text] [Related]  

  • 5. Liquid biopsy for liver diseases.
    Mann J; Reeves HL; Feldstein AE
    Gut; 2018 Dec; 67(12):2204-2212. PubMed ID: 30177542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of liquid biopsies in gastrointestinal cancer.
    Wu C; Zhang J; Li H; Xu W; Zhang X
    Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma.
    Reale A; Khong T; Xu R; Chen M; Mithraprabhu S; Bingham N; Spencer A; Greening DW
    Methods Mol Biol; 2021; 2261():151-191. PubMed ID: 33420989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid Biopsy in Solid Malignancy.
    Scarlotta M; Simsek C; Kim AK
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):284-296. PubMed ID: 30916594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Liquid Biopsies in Pediatric Brain Tumors.
    Tang K; Gardner S; Snuderl M
    J Neuropathol Exp Neurol; 2020 Sep; 79(9):934-940. PubMed ID: 32766689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of circulating biomarkers in liquid biopsy diagnostics.
    Yeo JC; Lim CT
    Biotechniques; 2018 Oct; 65(4):187-189. PubMed ID: 30284936
    [No Abstract]   [Full Text] [Related]  

  • 11. Liquid Biopsy Strategies to Distinguish Progression from Pseudoprogression and Radiation Necrosis in Glioblastomas.
    Yekula A; Muralidharan K; Rosh ZS; Youngkin AE; Kang KM; Balaj L; Carter BS
    Adv Biosyst; 2020 Dec; 4(12):e2000029. PubMed ID: 32484293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunities and challenges of circulating biomarkers in neuroblastoma.
    Trigg RM; Shaw JA; Turner SD
    Open Biol; 2019 May; 9(5):190056. PubMed ID: 31088252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid biopsies for multiple myeloma in a time of precision medicine.
    Ferreira B; Caetano J; Barahona F; Lopes R; Carneiro E; Costa-Silva B; João C
    J Mol Med (Berl); 2020 Apr; 98(4):513-525. PubMed ID: 32246161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research.
    Ramirez-Garrastacho M; Bajo-Santos C; Line A; Martens-Uzunova ES; de la Fuente JM; Moros M; Soekmadji C; Tasken KA; Llorente A
    Br J Cancer; 2022 Feb; 126(3):331-350. PubMed ID: 34811504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid Biopsy: Current Status and Future Perspectives.
    Mader S; Pantel K
    Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid Biopsy: General Concepts.
    Poulet G; Massias J; Taly V
    Acta Cytol; 2019; 63(6):449-455. PubMed ID: 31091522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and achievements of liquid biopsy technologies employed in early breast cancer.
    Alba-Bernal A; Lavado-Valenzuela R; Domínguez-Recio ME; Jiménez-Rodriguez B; Queipo-Ortuño MI; Alba E; Comino-Méndez I
    EBioMedicine; 2020 Dec; 62():103100. PubMed ID: 33161226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
    Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
    Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of liquid biopsies in colorectal cancer.
    Wills B; Gorse E; Lee V
    Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relevance of liquid biopsy in surgical oncology: The application of perioperative circulating nucleic acid dynamics in improving patient outcomes.
    Jordan PR; O'Leary DP; Fleming CA; Wang J; Redmond HP
    Surgeon; 2022 Aug; 20(4):e163-e173. PubMed ID: 34362650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.